Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis

Overview of attention for article published in Frontiers in Cell and Developmental Biology, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 14,469 followers.

RT @renesugar: Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis https://t.co/…

14 Feb 2024

Reply Repost Favourite

RT @renesugar: Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis https://t.co/…

12 Feb 2024

Reply Repost Favourite

RT @renesugar: Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis https://t.co/…

12 Feb 2024

Reply Repost Favourite

https://t.co/UTRsYxEkCW "The results indicate that metformin could have a systemic beneficiary effect on bone by inhibiting osteoclast formation and activity."

12 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.